Patient treatment preference in metastatic prostate cancer

40 male patients with metastatic prostate cancer given a choice of medical castration with the LHRH Analogue Goserelin (Zoladex) or surgical castration chose medical treatment. During a 15 month follow up only one patient decided to have an orchidectomy and this was because of treatment expense.